BackOMNI Health Overview

OMNI Health EBIT

Latest ebit for OMHE: $-460K, below the sector sector average of $2.5T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$49.50K
↓ 105.92% YoY

As of Jan 31, 2017

Annual EBIT (TTM)

-$461.52K
↓ 172.4% YoY

Trailing 12 months ending Jan 31, 2017

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

OMNI Health (OMHE) FAQ

The latest EBIT for OMHE is $-460K as of January 2017. That compares with $-170K in the prior-year period — down 172.4% year over year. That is below the sector sector average of $2.5T. Investors often review this figure alongside OMNI Health's historical trend and sector peers before judging valuation or financial health.

Over the past year, OMHE's EBIT moved from $-170K to $-460K — a 172.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in OMNI Health's operating scale or balance-sheet position.

Against its sector companies, OMHE currently prints $-460K for EBIT, while the sector average sits near $2.5T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at OMNI Health's growth, margins, and balance sheet.

A EBIT figure of $-460K for OMHE is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.5T. Explore the charts below for those layers of context.

After noting OMHE's EBIT ($-460K), review year-over-year change from $-170K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.